Mikro Biyosistemler Inc., a fabless biomedical microsystems company, has been established on 2015, as a spin-off from METU-MEMS Center. The company focuses on development of microfludics and lab-on-a-chip systems for biomedical applications including Multi-Drug-Resistance (MDR) and Circulating Tumor Cells (CTC) detection for early diagnosis and prognosis of cancer. Mikro Biyosistemler Inc. also provides consultancy and fabrication services for companies and institutions on microfluidics.
To become a worldwide recognized biomedical microsystems company creating solutions for biomedical applications, including:
Besides these, the company will create solutions for other research labs and companies working in microfluidics through consultancy for design and fabrication.
To convert the know-how and the patented cutting-edge technology developed at METU-MEMS Center into commercial products to set the gold standard in early cancer diagnosis, prognosis, and screening.
Based on the vision and mission of the MikroBiyosistemler Inc., the company will focus on two main products for the initial stages of the establishment, namely: MDR cancer cell detection system and CTC detection system from whole blood.
We are constantly expanding our activities and searching for skilled talents that share our passion for innovation. You can always submit your CV to email@example.com